(GCO) Genesco - Overview
Sector: Consumer Cyclical | Industry: Apparel Retail | Exchange: NYSE (USA) | Market Cap: 388m USD | Total Return: 69.4% in 12m
Avg Turnover: 4.98M
EPS Trend: -25.2%
Qual. Beats: 1
Rev. Trend: 62.8%
Qual. Beats: 0
Warnings
Extended 3d Choppy
Tailwinds
Idiosyncratic Leader
Genesco Inc. (NYSE: GCO) is a Nashville-based specialty retailer and wholesaler focused on footwear, apparel, and accessories. The company manages a multi-channel portfolio through four distinct segments: Journeys Group, Schuh Group, Johnston & Murphy Group, and Genesco Brands Group. Its operations span the United States, Canada, the United Kingdom, and the Republic of Ireland, utilizing a mix of physical storefronts and integrated e-commerce platforms.
The business model relies on a combination of proprietary brands, such as Johnston & Murphy, and licensed brands including Levis and Dockers. In the apparel retail sector, footwear retailers often face high inventory turnover requirements and sensitivity to cyclical consumer spending patterns. Genesco mitigates these risks by diversifying its target demographics, ranging from youth-oriented streetwear at Journeys to premium men’s professional attire at Johnston & Murphy.
Investors looking for deeper fundamental analysis may find ValueRay helpful for further research. Founded in 1934, the company maintains a long-standing presence in the wholesale distribution market while continuing to expand its digital footprint across several international domains.
- Journeys Group sales performance among teen consumers dictates overall corporate profitability
- Consumer discretionary spending trends in the US and UK impact retail traffic
- Inventory management and markdown strategies influence gross margins across footwear segments
- Expansion of Johnston & Murphy wholesale and e-commerce drives premium segment growth
- Rising operational costs and physical storefront rent pressure net income margins
| Net Income: 13.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.10 > 0.02 and ΔFCF/TA 6.96 > 1.0 |
| NWC/Revenue: 9.94% < 20% (prev 9.85%; Δ 0.09% < -1%) |
| CFO/TA 0.10 > 3% & CFO 145.8m > Net Income 13.3m |
| Net Debt (416.0m) to EBITDA (70.7m): 5.88 < 3 |
| Current Ratio: 1.64 > 1.5 & < 3 |
| Outstanding Shares: last quarter (10.7m) vs 12m ago -2.29% < -2% |
| Gross Margin: 46.26% > 18% (prev 0.47%; Δ 4.58k% > 0.5%) |
| Asset Turnover: 178.6% > 50% (prev 174.1%; Δ 4.47% > 0%) |
| Interest Coverage Ratio: 3.62 > 6 (EBITDA TTM 70.7m / Interest Expense TTM 4.80m) |
| A: 0.17 (Total Current Assets 618.5m - Total Current Liabilities 376.3m) / Total Assets 1.39b |
| B: 0.19 (Retained Earnings 265.8m / Total Assets 1.39b) |
| C: 0.01 (EBIT TTM 17.4m / Avg Total Assets 1.36b) |
| D: 0.29 (Book Value of Equity 240.2m / Total Liabilities 825.9m) |
| Altman-Z'' = 2.15 = BBB |
| DSRI: 0.78 (Receivables 39.8m/48.9m, Revenue 2.44b/2.33b) |
| GMI: 1.02 (GM 46.26% / 47.17%) |
| AQI: -0.88 (AQ_t -0.04 / AQ_t-1 0.05) |
| SGI: 1.05 (Revenue 2.44b / 2.33b) |
| TATA: -0.10 (NI 13.3m - CFO 145.8m) / TA 1.39b) |
| Beneish M = -4.37 (Cap -4..+1) = AAA |
As of May 26, 2026, the stock is trading at USD 37.02 with a total of 133,800 shares traded.
Over the past week, the price has changed by +11.98%,
over one month by +4.58%,
over three months by +38.34% and
over the past year by +69.35%.
Genesco has received a consensus analysts rating of 3.00. Therefore, it is recommended to hold GCO.
- StrongBuy: 0
- Buy: 0
- Hold: 3
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 36 | -2.8% |
P/E Trailing = 26.8346
P/E Forward = 15.528
P/S = 0.1591
P/B = 0.6401
P/EG = 0.6838
Revenue TTM = 2.44b USD
EBIT TTM = 17.4m USD
EBITDA TTM = 70.7m USD
Long Term Debt = 3.38m USD (from longTermDebt, last quarter)
Short Term Debt = 238.4m USD (from shortTermDebt, last quarter)
Debt = 521.4m USD (from shortLongTermDebtTotal, last quarter) (leases 518.0m already included)
Net Debt = 416.0m USD (calculated: Debt 521.4m - CCE 105.4m)
Enterprise Value = 803.5m USD (387.5m + Debt 521.4m - CCE 105.4m)
Interest Coverage Ratio = 3.62 (Ebit TTM 17.4m / Interest Expense TTM 4.80m)
EV/FCF = 5.51x (Enterprise Value 803.5m / FCF TTM 145.8m)
FCF Yield = 18.14% (FCF TTM 145.8m / Enterprise Value 803.5m)
FCF Margin = 5.98% (FCF TTM 145.8m / Revenue TTM 2.44b)
Net Margin = 0.54% (Net Income TTM 13.3m / Revenue TTM 2.44b)
Gross Margin = 46.26% ((Revenue TTM 2.44b - Cost of Revenue TTM 1.31b) / Revenue TTM)
Gross Margin QoQ = 45.89% (prev 46.84%)
Tobins Q-Ratio = 0.58 (Enterprise Value 803.5m / Total Assets 1.39b)
Interest Expense / Debt = 0.92% (Interest Expense 4.80m / Debt 521.4m)
Taxrate = 6.38% (3.24m / 50.8m)
NOPAT = 16.3m (EBIT 17.4m * (1 - 6.38%))
Current Ratio = 1.64 (Total Current Assets 618.5m / Total Current Liabilities 376.3m)
Debt / Equity = 0.92 (Debt 521.4m / totalStockholderEquity, last quarter 567.0m)
Debt / EBITDA = 5.88 (Net Debt 416.0m / EBITDA 70.7m)
Debt / FCF = 2.85 (Net Debt 416.0m / FCF TTM 145.8m)
Total Stockholder Equity = 527.4m (last 4 quarters mean from totalStockholderEquity)
RoA = 0.97% (Net Income 13.3m / Total Assets 1.39b)
RoE = 2.52% (Net Income TTM 13.3m / Total Stockholder Equity 527.4m)
RoCE = 3.28% (EBIT 17.4m / Capital Employed (Equity 527.4m + L.T.Debt 3.38m))
RoIC = 1.33% (NOPAT 16.3m / Invested Capital 1.23b)
WACC = 6.20% (E(387.5m)/V(908.9m) * Re(13.38%) + D(521.4m)/V(908.9m) * Rd(0.92%) * (1-Tc(0.06)))
Discount Rate = 13.38% (= CAPM, Blume Beta Adj.) -> capped to 13.17%
Shares (quarterly) Correlation: -60.0 | Cagr: -0.99%
[DCF] Terminal Value 77.97% ; FCFF base≈106.2m ; Y1≈121.7m ; Y5≈179.1m
[DCF] Fair Price = 209.9 (EV 2.70b - Net Debt 416.0m = Equity 2.28b / Shares 10.9m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -25.25 | EPS CAGR: -21.83% | SUE: 0.88 | # QB: 1
Revenue Correlation: 62.80 | Revenue CAGR: 1.15% | SUE: 0.42 | # QB: 0
EPS current Quarter (2026-07-31): EPS=-1.17 | Chg30d=-29.72% | Revisions=-33% | Analysts=4
EPS current Year (2027-01-31): EPS=2.13 | Chg30d=-5.11% | Revisions=-14% | GrowthEPS=+47.2% | GrowthRev=-0.2%
EPS next Year (2028-01-31): EPS=2.74 | Chg30d=-8.67% | Revisions=+0% | GrowthEPS=+28.3% | GrowthRev=+2.1%
[Analyst] Revisions Ratio: -33%